Clinical trials recruiting in Gangnam-gu, South Korea
8
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 3Phase 3 6
Conditions recruiting in Gangnam-gu, South Korea
Recruiting trials in Gangnam-gu, South Korea
- A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Common questions
How many clinical trials are recruiting in Gangnam-gu, South Korea?
8 recruiting trials have at least one study site in Gangnam-gu, South Korea.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.